MindMed to Present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference
![Business Wire](../../../Content/images/providers/BW.png)
Mind Medicine (MindMed) Inc. - Common Shares (MNMD)
Company Research
Source: Business Wire
NEW YORK--(BUSINESS WIRE)--Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the “Company” or “MindMed”), a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders, announced today that members of the Company’s management team will present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference being held on June 27, 2024.A webcast of the fireside chat will be accessible on MindMed’s Investor Relations website starting on June 27, 2024 at 7:00 AM ET and will remain available for replay on the website for up to 90 days following the event.About MindMedMindMed is a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders. Our mission is to be the global leader in the development and delivery of treatments that unlock new opportunities to improve patient outcomes. We are developing a pipeline of innovative product candidates, with and without acute perceptual effects, t
Show less
Read more
Impact Snapshot
Event Time:
MNMD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MNMD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MNMD alerts
High impacting Mind Medicine (MindMed) Inc. - Common Shares news events
Weekly update
A roundup of the hottest topics
MNMD
News
- MindMed to be Included in Russell 2000® and Russell 3000® IndexesBusiness Wire
- UN Warns of Health Dangers in Commercial Psychedelic Drug Use [BNN Bloomberg (Canada)]BNN Bloomberg
- Startup's ‘Fentanyl Vaccine' Aims to Block Drug's Highs, Overdoses [BNN Bloomberg (Canada)]BNN Bloomberg
- Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.MarketBeat
- MindMed Announces Constructive End-of-Phase 2 Meeting with U.S. FDA for MM120 in Generalized Anxiety Disorder (GAD)Business Wire
MNMD
Earnings
- 5/8/24 - Miss
MNMD
Sec Filings
- 6/28/24 - Form 8-K
- 6/28/24 - Form S-3ASR
- 6/28/24 - Form S-8
- MNMD's page on the SEC website